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Signal Enhanced Proteomics: a Biological Perspective on Dissecting the 
Functional Organisation of Cell Proteomes 
Running title: Signal Enhanced Proteomics
Abstract 
Proteomes are highly dynamic and can respond rapidly to environmental and cellular 
signals. Within cells, some proteins can form distinct ‘pools’, i.e. where a subset of the 
protein shows different functions and/or properties, such as subcellular location. This 
means that for a given protein ‘A’, a subset (pool) of that protein can differ in a value 
that is measured for the total population of molecules of protein ‘A’. However, in 
quantitative proteomics studies it is common to measure averaged values for proteins 
that do not reflect variations that may occur between different protein isoforms, 
different subcellular compartments, or in cells at different cell cycle stages.  Here we 
review experimental approaches that can be used to enhance the signal from specific 
pools of protein that may otherwise be obscured through averaging across protein 
populations. This signal enhancement can help to reveal functions associated with 
specific protein pools, providing insight into the regulation of cellular processes. We 
review different strategies for proteomic signal enhancement, with a focus on the 
analysis of protein pools in different subcellular locations. We describe how MS-based 
proteome analyses can be combined with a general physico-chemical cell fractionation 
procedure that can be applied to many cultured cell lines.  
Introduction 
The field of proteomics has seen tremendous advances that have improved the 
efficiency of protein detection at multiple levels, including experimental design, sample 
preparation workflows, LC-MS instrumentation and computational analysis. As a 
result, it is now possible not only to identify a large proportion of a steady state cell 
proteome in a single experiment, either with, or without, fractionation [1,2] but also to 
describe additional proteome dimensions, such as protein turnover rates, cell-to-cell 
variation, post-translational modifications, and subcellular localization. 
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From a biological perspective, a limitation of most shotgun proteomics experiments is 
that protein extracts are typically prepared from heterogeneous populations of cells, 
e.g. either from tissues, whole organisms, or from unsynchronised cells at different cell 
cycle stages. The resulting quantitative data represent an averaged value across all 
of the pools of each protein. However, to characterise biological regulatory 
mechanisms, it is important not only to quantify protein expression levels, but also to 
resolve protein groups into separate isoforms. This “isoform inference” problem is 
inevitably associated with bottom-up proteomics; i.e. where proteins extracted from a 
cell, tissue or an organelle are identified following their digestion into peptides, which 
are then analysed using LC-MS/MS. Furthermore, information from additional 
proteome ‘dimensions’ e.g. describing the subcellular distribution of proteins and 
cross-correlating this with data on post-translational modifications (PTMs), protein 
complexes, rates of protein synthesis and turnover, can provide valuable insights into 
regulatory mechanisms and generate hypotheses that can be evaluated in follow-on 
experiments. This combined analysis approach has been referred to as either “Next 
Generation Proteomics”, or, “Multidimensional Proteomics” [3]. 
In this manuscript, we will review examples of methods that make it possible to 
enhance proteomic signals and thereby detect protein-level changes that would not 
have been detected in standard one-dimensional analyses.  
 
Signal enhanced proteomics vs Classical proteomics 
 
Most proteomics approaches have tended to provide measurements that describe an 
averaged view, or steady state proteome. Protein expression levels are measured 
from the combined analysis of different sub-populations of protein molecules extracted 
from homogenized cell or tissue extracts. In turn, the extracts are generated from pools 
of cells, which typically include cells at different stages of the cell cycle and may 
include cells that have shown different response levels to external stimuli. While this 
is useful in providing general information on the proteome and its remodelling, as 
described below, the averaging can obscure the detection of changes in proteins that 
occur specifically in subsets of the global proteome (Figure 1). 
 
To address the population averaging problem, several enrichment strategies at either 
cellular, or subcellular levels, can be applied to link the proteomics information more 
effectively with cell biology. For example, immunologists have long used surface 
markers to label and sort different subpopulations of immune cells, using Fluorescence 
Activated Cell Sorting (FACS). With recent improvements in sensitivity and throughput 
for MS analysis, it has become technically feasible and cost effective to combine FACS 
sorting with proteomics analysis, which helps to target protein detection in specific cell 
subsets [4,5]. Recently, Ly et al. extended this approach to using FACS also to isolate 
cell subpopulations defined by immunolabelling intracellular, rather than cell surface 
antigens [6]. Using this strategy, termed PRIMMUS (PRoteomic analysis of 
Intracellular iMMUnolabelled cell Subsets), Ly et al. were able to separate interphase 
and mitotic cells, and also able to isolate populations of FACS-sorted cells enriched 
for specific mitotic subphases in sufficient quantities for detailed MS-based proteomic 
analysis, as shown schematically in Figure 1. For example, using PRIMMUS allowed 
the identification of 115 protein phosphorylation sites that increased during G2, 
including the phosphorylation of serine S738 on TPX2, which was shown to be 
important for TPX2 function and mitotic progression. This demonstrates that even 
minor subsets of cells in a population, which exist only transiently, can be isolated and 
protein responses detected that would otherwise be obscured in the bulk analysis of 
the proteome in extracts prepared from mixtures of cells at different cell cycle stages. 
New technology platforms are now being developed, based on FACS, to allow 
proteomics analysis from low numbers of cells, even aiming at single cell analysis. For 
example, Zhu et al. described the use of FACS to deposit cells into a newly developed 
nanodroplet sample processing chip for nanoLC-MS analysis [7]. This allowed the 
identification of ~ 670 protein groups from a single HeLa cell. They further 
demonstrated that this single cell platform can differentiate cell types from enzyme‐
dissociated human lung primary cells and identify specific protein markers for epithelial 
and mesenchymal cells. 
 
Isoform specific proteomics  
In higher eukaryotes, many genes encode two or more protein isoforms, which behave 
as distinct pools of related proteins and that may differ in terms of subcellular 
localization, interaction partners and function. For example, alternative splicing of pre-
mRNA transcripts is commonplace, generating multiple mRNAs from the same gene, 
which in turn gives rise to proteins that can differ in structure and function. Isoforms 
can also arise via differential protein processing, e.g. cleaving the original translation 
product into shorter forms. In other cases, protein isoforms can arise from expression 
of closely related, duplicated genes. 
Whatever the mechanism, a common feature of closely related protein isoforms is that 
they usually share extensive regions of protein sequence identity and consequently 
have many shared peptides. The corollary is that many peptides that are identified in 
the typical bottom-up MS-based proteomics workflows cannot reliably be assigned to 
only one specific protein species for quantitation (Figure 2). If the structure of different 
protein isoforms is known experimentally, or predicted from genomic and 
transcriptomic studies, peptides that are either unique to a specific isoform, or shared 
between different isoforms, can be identified and used for MS-based quantification. 
However, the identities of all protein isoforms in different cell types and organisms are 
not always known in advance. To address the isoform problem experimentally, without 
relying on accurate genome annotations, a protein size fractionation step can be 
included in the workflow, e.g. using SDS-PAGE, or size exclusion chromatography 
(SEC), prior to digestion [8-10]. This can enrich for protein isoforms that differ in size, 
which in turn reduces the isoform inference problem in subsequent MS analysis. 
Computational approaches can also be used to distinguish protein isoforms. For 
example, Ahmad et al. [11] used a candidate approach, combined with sub-cellular 
fractionation, to detect protein isoforms that showed differential behaviour in separate 
subcellular compartments. Here, average values for protein intensity are first 
calculated using all of the peptides detected from a given gene, irrespective of 
isoforms. Next, the potential protein coding region is subdivided along its length and 
protein intensity is re-calculated, either using the peptides from the respective amino 
terminal, middle and carboxy-terminal ‘thirds’ of the protein sequence (‘rule of thirds’ 
approach), or else protein intensity calculated using groups of adjacent peptides, 
moving sequentially along the protein length from the amino to carboxy terminus. The 
principle is that if a protein isoform has a region of peptide sequence that is not present 
in other isoforms (e.g. resulting from inclusion of a differentially spliced exon), that may 
result in a protein intensity value for the isoform that differs from the average value 
obtained using all of the peptides matched to the protein group. Using the unbiased 
approach described above, Ahmad et al. [11] detected candidate protein isoforms via 
the analysis of peptide subsets and showed that the expression of some of these 
isoforms differed between the respective cytoplasmic and nuclear compartments of 
cultured human cell lines. 
Ahmad et al. [11] also analysed correlations between protein post-translational 
modifications (PTMs) and protein localisation and turnover rates. For example, this 
showed that while the presence of one or more phosphorylated residues had little or 
no effect on the mean protein turnover rate, a subset of proteins were identified for 
which phosphorylation correlated with altered turnover rates. Interestingly, in HeLa 
cells this also correlated with protein localisation. Thus, a larger fraction of nucleolar 
proteins showed effects of phosphorylation on turnover rates, as opposed to either 
cytoplasmic, or nuclear proteins. Gene ontology analysis showed further that the 
proteins whose turnover rates are most affected by phosphorylation were enriched for 
ATP and nucleotide binding proteins, multiple cell cycle regulated proteins and 
proteins involved in apoptosis and cell death response mechanisms. 
An alternative approach to identifying protein isoforms is to use a ‘top down’ MS 
strategy, rather than the more common ‘bottom up’ shotgun MS strategy discussed 
above. The top down strategy relies upon the ability to identify intact proteins by MS, 
rather than digested peptides [12]. The analysis of intact proteins can provide more 
accurate information, e.g. on the size of the proteins, on the presence of splice forms 
and PTMs [13-17]. Moreover, this approach can potentially provide more accurate 
quantification by overcoming many of the problems inherent in quantification using 
bottom up strategies. Currently, application of the top down strategy is still limited, at 
least in part, by the resolution and throughput capacity of modern MS instruments. 
However, the ability to resolve intact proteins by MS has improved significantly in 
recent years and we anticipate that further improvements will result in a wider adoption 
of the top down strategy in future. 
 
The subcellular proteome  
 
While most proteomic analyses have studied whole cell extracts, avoiding the issue of 
subcellular protein localization, some studies have focussed on analysing the 
proteomes of purified organelles and more recently global approaches have been 
developed to tackle the spatial dimension of the proteome. These global proteome 
localization approaches can be divided into two groups: first, targeted studies, which 
attempt to isolate biologically defined compartments (organelles), using fractionation 
methods that yield relatively pure fractions; second, global studies where multiple 
fractions are generated, using characteristics of subcellular compartments, e.g. 
density and solubility to detergents, as the basis for fractionation. Subsequently, cross-
gradient profiles are used to group proteins and assign them to compartments, based 
on co-fractionating markers. 
Examples of methods from the first group include the classic nucleolar extraction 
protocol, which has been used in the “spatial proteomics” workflow (Figure 3A) [18] as 
well as methods using detergents of increasing strength to target compartment 
proteomes, based on their accessibility and solubility [10]. Methods which belong in 
the second group include Protein Correlation Profiling (PCP) [19] and Localization of 
Organelle Proteins by Isotope Tagging (LOPIT) [20], both of which rely on statistical 
methods to unravel the pattern of distribution of compartment proteomes in mixed 
populations separated using a gradient fractionation approach. The LOPIT workflow 
has been used successfully to investigate how the proteome, at steady state, is 
partitioned between multiple organelles and compartments. LOPIT has taken 
advantage of isobaric labelling, such as iTRAQ [21] and TMT[22], which allows 
simultaneous analysis of up to ten samples in a single MS run. Isobaric labelling is 
particularly well suited for analysis of fractionation experiments, because physically 
combining fractions early in the workflow makes the analysis internally controlled and 
improves data quality by reducing the problem of missing values.  
Hyperplexed LOPIT [23] leverages new technological development, both in the TMT-
technology and MS instrumentation, allowing more accurate quantification of an 
increased range of reporter tags. In addition to higher multiplexing capabilities, 
HyperLOPIT features improved subcellular fractionation protocols, which aim to 
preserve as many sub-organelles as possible [24]. Another important part of any 
spatial proteomics approach is the computational workflow used to combine the 
proteomics data with the subcellular fractionation/organelle compartment information.  
Accordingly, considerable effort has been dedicated to the development of 
computational packages for spatial proteomics in recent years.  For example, Breckels 
et al., have recently described an example of a spatial analysis workflow combined 
with a step by step analysis guide [25]. An overview of a data analysis workflow for 
spatial proteomics is illustrated in Figure 3B. 
In addition to characterising organelle/compartment proteomes at steady state, it is 
also important to understand the dynamic remodelling of the subcellular proteome 
when cells respond to stimuli, e.g. stress, or viral infection.  This can result not only in 
changes in protein abundance, but also in protein translocation between 
compartments. Recently, Cristea and co-workers extended the methods described 
above to study virus-induced spatial cell remodelling. By combining label-free and 
isobaric labelling, they measured the abundance levels for host and viral proteins and 
their localization throughout the time course of human cytomegalovirus (HCMV) 
infection, providing a comprehensive resource for understanding host and virus 
biology during HCMV pathogenesis [26,27]. They reported global reorganisation of 
proteins across different cellular compartments, including reorganization and 
processing of lysosomal proteins into distinct pools and translocations of individual 
proteins between organelles at specific timepoints. They also demonstrated that 
translocation of an unconventional myosin, MYO18A, from the plasma membrane to 
the viral assembly complex, is necessary for efficient HCMV replication. 
The extent of proteome relocalization is also affected by the cell genotype, as first 
shown by comparing the response to stress induced by DNA damage in human 
HCT116 cells that were either wild type, or null, for the tumour suppressor p53 [28]. 
Using a MS-based proteomics approach, combined with subcellular fractionation, the 
distribution of the proteome between the nucleus and cytoplasm was compared before 
and after DNA damage induced by etoposide treatment, in both p53 +/+ and p53 -/- 
HCT116 cells. Few p53-dependent differences in proteome localization were detected 
under normal cell growth conditions, but clear differences after induction of DNA 
damage, particularly affecting the ability of ribosomal proteins to accumulate in 
nucleoli. This study illustrates how the unbiased proteomic analysis of part of the role 
of p53 in the DNA damage response was only revealed after linking MS-based 
proteome measurements with subcellular fractionation. 
Protein turnover analysis 
Early biochemical studies of protein turnover relied on detecting the incorporation of 
radiolabeled amino acids into newly translated proteins [29]. Typically, proteins were 
labelled with [35S] methionine and pulse-chase experiments used to determine their 
rate of degradation, after adding drugs to block protein synthesis. Nowadays, MS-
based proteomics allows the measurement of turnover rates for large numbers of 
proteins simultaneously, for example by using pulse labelling experiments combined 
with stable isotope labelling by amino acids in cell culture (SILAC). The principle of 
pulse SILAC is to metabolically label proteins with heavy isotope substituted amino 
acids and then to quantify how the isotope-labelled protein population changes over 
time (Figure 4). We and others have used pulse SILAC to study protein synthesis and 
turnover [10,30-36]. 
An alternative method is metabolic labelling using bioorthogonal amino acids [37], 
such as azidohomoalanine (AHA), which is incorporated into newly synthesised 
proteins instead of methionine [38]. AHA contains an azide group, enabling capture of 
newly synthesised proteins via click chemistry [37]. This, combined with SILAC, 
enables short pulse times [39,40]. 
Recently, protein turnover has been studied in high throughput by an MS-based 
approach combining SILAC and TMT labelling [41], which helped to address the 
problem of missing data between the time points, while allowing different proteoforms 
to be resolved by providing peptide-level measurements of turnover rates.  Another 
example of peptide level turnover data was recently reported by Ly et al. in 
immortalised human breast epithelial cells [42], who used pulse-SILAC and cellular 
assays to study the activation of v-Src tyrosine kinase activity in untransformed 
MCF10A cells. v-Src induced rapid oncogenic transformation, with the cells showing 
major phenotypic changes within 48-72 hours, affecting their morphology, motility and 
invasiveness. Over this time course, the expression and/ or turnover levels of only 
~3% of proteins changed by 2-fold or more. Furthermore, since many of the 
transformation-responsive proteins were low abundance, oncogenic transformation 
affected only ~ 1.5% of the total protein molecules in the MCF10A proteome.  
Protein turnover rates can vary for separate pools of the same protein located in 
different subcellular compartments (Figure 4). For example, this was identified for 
ribosomal proteins in HeLa cells using a combination of pulsed stable isotope labelling 
with SILAC and fluorescence microscopy [33,43]. There was a higher rate of ribosomal 
protein turnover in HeLa cell nuclei than in the cytoplasm. Newly translated ribosomal 
proteins are immediately imported into the nucleus, ready for assembly into nascent 
ribosomal subunits in the nucleolus. If not bound to rRNA, however, free ribosomal 
proteins in this nuclear pool are rapidly degraded. Ribosomal protein stability was 
dramatically increased upon assembly into ribosome subunits and export to the 
cytoplasm [43]. 
Another example showing how different pools of the same proteins can exhibit 
differential turnover rates was provided in a study on the assembly of RNA polymerase 
II complexes by Boulon et al. [44] By using pulsed SILAC to analyse protein turnover 
rates, combined with subcellular fractionation, they studied the assembly of RNA 
polymerase II, which occurs predominantly within the cytoplasm. After its assembly is 
completed, RNA polymerase II is transported into the nucleus, thereby preventing 
partially assembled and potentially non-functional sub-polymerase complexes 
competing for binding to gene promoters. The pulse-SILAC data showed that, similar 
to the situation with ribosomal proteins, protein turnover rates for subunits of the large 
polymerase complexes are higher in the cytoplasmic compartment, where assembly 
takes place, as opposed to the nucleus, where the complex functions (note the roles 
of these compartments is reversed for ribosome subunits). 
Systematic proteome level analyses of the relation between protein turnover levels 
and subcellular localization were carried out, using unbiased MS approaches in U2OS 
cells, by Larance et al., 2013 [10]. This study systematically compared protein turnover 
levels in the respective nuclear, cytosolic, membrane and cytoskeletal compartments, 
revealing an important feedback mechanism, whereby inhibition of protein degradation 
by the proteasome resulted in a rapid inhibition of new protein translation, mediated 
by induced phosphorylation of eIF2alpha. Importantly, all of these studies together 
show that protein half-life values based only on analyses of whole cell extracts provide 
average values that can mask the existence of pools of protein with different 
properties. 
Concluding Remarks 
In this manuscript we have highlighted some of the practical issues involved in 
integrating data from MS-based proteomic studies with functional studies in cell 
biology. In particular, we have focussed on how proteomics can be used to study 
subcellular localization and to identify pools of protein and distinct protein isoforms that 
can exhibit differences in structure and properties (e.g. turnover rate, interaction 
partners and PTMs) in different subcellular compartments. This information can be 
critical for understanding biological regulatory and response mechanisms, but is often 
lost or obscured in proteomic studies because of the effect of cell and protein 
population averaging when whole cell or tissue extracts are analysed.  
Subcellular fractionation approaches ([20,23,24,26,27]) can be conveniently applied 
in a multi-dimensional proteomics strategy to improve the functional analysis of cell 
proteomes [24] and in the characterization of spatial remodelling following a 
perturbation such as viral infection [26,27]. As shown for the role of p53 in the cellular 
response to DNA damage [28] characterising how subcellular proteome dynamics is 
affected by genotype will also be important and can now be analysed more 
systematically in human cells thanks to the availability of genome engineering 
technology with CRISPR/Cas9. We anticipate that in future more detailed studies 
examining the composition and dynamic remodelling of organelle proteomes at a 
multidimensional level will help to reveal new insights into the specific protein 
complexes and functional pools of proteins and isoforms that participate in cell 
regulatory mechanisms and metabolism.  
 
 
Acknowledgements 
This work was funded by awards from the Wellcome Trust 073980/Z/03/BR and  
098503/Z/12/Z and a BBSRC sLoLa grant BB/K003801/1. Imaging and image analysis 
was supported by two Wellcome Trust Strategic Awards (097945/B/11/Z and 
095931/Z/11/Z) and an MRC Next generation Optical Microscopy Award 
(MR/K015869/1). 
  
Legends 
 
Figure 1 
Schematic comparing classic ‘averaged’ proteomics analysis and signal enhanced 
proteomics. When a population of cells in culture is subjected to external stimuli, some 
cells may respond differently, resulting in a heterogeneous population, shown here as 
red and blue cells. In a classical proteomics experiment, cell extracts are prepared 
from the mixed population, resulting in averaged protein signals. With ‘Signal 
Enhanced Proteomics’, the two populations of cells are separated prior to proteomics 
analysis, thus reducing the dilution of the signal for proteins in a specific subpopulation 
of cells. For example, in a classic proteomics experiment, without an enrichment step, 
the peptide denoted with (*) was not selected for fragmentation because it was below 
the intensity threshold (red dashed line). However, after cell enrichment, the intensity 
of this peptide was now above the threshold intensity required for sequencing and 
hence could be detected.  
 
Figure 2  
Isoform-specific Proteomics. A schematic representation of how a single gene can 
encode two protein isoforms as a result of alternative splicing. These isoforms 
extensively share their protein sequence, but differ in specific segments, exemplified 
here by the blue and red peptide sequences. The two protein isoforms may have 
different properties, such as different subcellular localizations, which will only be 
resolved if sub-cellular fractionation is used prior to the proteomics analysis. 
 
Figure 3 
An example of a spatial proteomics workflow. A) A detailed subcellular fractionation 
protocol, based on the nucleolar isolation protocol, but with the number of subcellular 
fractions collected extended, thus increasing the resolution of proteomics 
measurements. Total cell lysate (TCL) is included as a control in subsequent analyses. 
B) A data analysis workflow, including a protein size separation step, using SDS-
PAGE, of extracts from subcellular fractions, followed by LC-MS/MS. Raw files are 
analysed in MaxQuant [45,46], then peptide files re-assembled from individual 
evidence entries, analysed by Re-Fraction [47] to resolve protein groups into single 
protein IDs wherever possible. Protein cross-fraction profiles are generated from 
assigned peptide profiles. Protein profiles are clustered, using either a hierarchical, or 
k-means algorithm and predictive localization(s) assigned, based on their distance to 
co-clustering markers in the abundance space. 
 
Figure 4 
Compartment-specific protein turnover measurements. Pulse SILAC can be combined 
with sub-cellular fractionation to measure protein turnover in different subcellular 
compartments. A) Cells are cultured in different SILAC media, containing either “light” 
(L, K0R0), or “medium” (M, K4R6) isotope substituted forms of the amino acids 
arginine and lysine, until all proteins are fully labelled. The culture medium of the cells 
growing with the “medium” amino acids is then replaced with a culture medium 
containing “heavy” (H, K8R10) substituted versions of arginine and lysine. Finally, cells 
are harvested at different time points, along with the control cells growing in the culture 
medium containing normal, “light” (i.e. unsubstituted) arginine and lysine. Equal 
numbers of control and pulsed cells are then combined, prior to protein isolation and 
analysis. Either whole cell extracts can be prepared cells from each time point, or 
extracts prepared from cells that are fractionated, e.g. into cytoplasmic, nuclear and 
nucleolar fractions, as illustrated. The subsequent proteomics analyses allow the 
measurements of rates of protein synthesis, degradation and turnover. B) For a given 
protein, the change in isotope ratios over time measure, respectively, (i) the rate of 
protein degradation (M/L isotope ratio), (ii) the rate of protein synthesis (H/L isotope 
ratio) and (iii) the rate of net protein turnover (H/M isotope ratio). C) Turnover data can 
be collected for different subcellular compartments, revealing proteins and protein 
isoforms that differ in their turnover rates according to their localization. 
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